A nurse is reviewing a client's medical record and notes that the client is taking tamoxifen.
The nurse should identify that tamoxifen is used to treat which of the following conditions?
Non-Hodgkin's lymphoma.
Endometriosis.
Breast cancer.
Polycystic ovary syndrome.
The Correct Answer is C
Choice A rationale:
Tamoxifen is not used to treat Non-Hodgkin's lymphoma. Tamoxifen is a selective estrogen
receptor modulator (SERM) and is primarily used in breast cancer treatment. It functions by
binding to estrogen receptors, blocking estrogen's effects, and inhibiting the growth of
hormone-sensitive breast cancer cells.
Choice B rationale:
Tamoxifen is not used to treat endometriosis. Endometriosis is a condition in which tissue
similar to the lining of the uterus grows outside the uterus, and it is typically managed with
hormonal therapies, pain medications, or surgical interventions, but not tamoxifen.
Choice C rationale:
This is the correct choice. Tamoxifen is widely used in the treatment of breast cancer,
especially in cases of estrogen receptor-positive breast cancer. It helps prevent cancer
recurrence and is often prescribed for both early-stage and advanced breast cancer patients.
Choice D rationale:
Tamoxifen is not used to treat polycystic ovary syndrome (PCOS). PCOS is a hormonal
disorder characterized by enlarged ovaries with small cysts, and it is typically managed with
lifestyle changes, hormonal contraceptives, and medications to regulate menstrual cycles and
manage symptoms like hirsutism and acne.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
Choice A rationale:
Raloxifene is not used to treat migraines. It is a selective estrogen receptor modulator (SERM) that primarily acts on bone tissues, estrogen receptors, and has anti-estrogenic effects in the breast, which may reduce the risk of breast cancer.
Choice B rationale:
Raloxifene is not used to treat hypertension (high blood pressure) It is primarily indicated for the prevention and treatment of osteoporosis in postmenopausal women.
Choice C rationale:
This is the correct choice. Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women. It helps increase bone density and reduces the risk of fractures associated with osteoporosis.
Choice D rationale:
Raloxifene is not used to treat heart disease. While it may have some cardiovascular benefits due to its effects on cholesterol levels, it is not a primary medication for heart disease management.
Correct Answer is D
Explanation
Choice A reason:
Preparing for an amnioinfusion is not the first-line action. It may be considered if decelerations do not resolve with initial measures such as maternal repositioning.
Choice B reason:
Administering oxygen is a subsequent measure if initial interventions like repositioning do not improve the FHR. Oxygen is typically given at 8-10 L/min via a nonrebreather mask to increase fetal oxygenation.
Choice C reason:
Discontinuing oxytocin is important if the cause of decelerations is uterine hyperstimulation. However, repositioning the client should precede this action to quickly address potential umbilical cord compression.
Choice D reason:
This is the first action to take because it can quickly alleviate potential compression of the umbilical cord, which is often the cause of variable decelerations. It may be considered if decelerations do not resolve with initial measures such as maternal repositioning.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today